SECreport
Form 4 CASI Pharmaceuticals, For: Sep 28 Filed by: Chi George
Last casi pharmaceuticals, inc earnings: 11/14 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: casipharmaceuticals.com/investor-relations
| IMPACT SNAPSHOT | EVENT TIME: | CASI | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
CASI alerts
CASI alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CASI alerts
High impacting CASI Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics
CASI
NEWS
NEWS
- CASI Pharmaceuticals Announces China National Medical Products Administration (NMPA) Approval Of CTA To Conduct Confirmatory Clinical Trial For ZEVALIN®[PR Newswire]
- CASI Pharmaceuticals Inc (NASDAQ: CASI) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating.[MarketBeat]
- CASI Pharmaceuticals (CASI) Presents At BIO CEO & Investor Conference - Slideshow [Seeking Alpha][Seeking Alpha]
- CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference[PR Newswire]
- CASI Pharmaceuticals Inc (NASDAQ: CASI) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating.[MarketBeat]
- More
CASI
SEC Filings
SEC Filings
- 2/19/19 - Form 8-K
- 2/6/19 - Form SC
- 2/6/19 - Form SC
- CASI's page on the SEC website
- More